<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glazmag</journal-id><journal-title-group><journal-title xml:lang="ru">The EYE ГЛАЗ</journal-title><trans-title-group xml:lang="en"><trans-title>The EYE GLAZ</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2222-4408</issn><issn pub-type="epub">2686-8083</issn><publisher><publisher-name>Академия медицинской оптики и оптометрии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33791/2222-4408-2023-2-151-162</article-id><article-id custom-type="elpub" pub-id-type="custom">glazmag-445</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Оптические методы управления прогрессирующей миопией</article-title><trans-title-group xml:lang="en"><trans-title>Optical methods for the management of progressive myopia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4130-4815</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мягков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Myagkov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мягков Александр Владимирович, доктор медицинских наук, профессор, директор</p><p>125438, Российская Федерация, г. Москва, ул. Михалковская, д. 63б, стр. 4</p></bio><bio xml:lang="en"><p>Alexander V. Myagkov, Dr. Sci. (Med.), Professor, Director</p><p>63b, bld. 4, Mikhalkovskaya Str., Moscow, 125438, Russian Federation</p></bio><email xlink:type="simple">6425908@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-1987-5737</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мягков</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Myagkov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мягков Даниил Александрович, оптометрист отдела ортокератологии и контроля миопии</p><p>125438, Российская Федерация, г. Москва, ул. Михалковская, д. 63б, стр. 4</p></bio><bio xml:lang="en"><p>Daniil A. Myagkov, Optometrist of the Department of Orthokeratology and Myopia Control </p><p>63b, bld. 4, Mikhalkovskaya Str., Moscow, 125438, Russian Federation</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>АНО «Национальный институт миопии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Myopia Institute</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>04</day><month>07</month><year>2023</year></pub-date><volume>25</volume><issue>2</issue><fpage>151</fpage><lpage>162</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Академия медицинской оптики и оптометрии, 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Академия медицинской оптики и оптометрии</copyright-holder><copyright-holder xml:lang="en">Академия медицинской оптики и оптометрии</copyright-holder><license xlink:href="https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.theeyeglaz.com/jour/article/view/445">https://www.theeyeglaz.com/jour/article/view/445</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Близорукость является основной причиной предотвратимой слепоты и распространяется по всему миру с угрожающей скоростью, особенно в азиатских странах. Возраст начала близорукости понижается, а процентное соотношение высокой миопии резко возрастает, что требует от специалистов применения современных безопасных методов ее стабилизации для предотвращения осложнений в будущем. Сегодня предпочтение отдается оптическим методам контроля миопии, основанным на формировании наведенного периферического миопического дефокуса.</p></sec><sec><title>Цель</title><p>Цель: изучить отечественный и международный опыт применения оптических методов лечения прогрессирующей миопии. Выявить факторы, влияющие на их эффективность.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведен анализ более 200 источников на ресурсах PubMed, eLibrary, Crossref Metadata за последние 10 лет. В работу вошел обзор 60 публикаций.</p></sec><sec><title>Результаты</title><p>Результаты. В последние годы отмечается активный интерес исследователей к проблеме прогрессирующей миопии. Это отражается более чем четырехкратным ростом количества статей, посвященных причинам развития и методам лечения прогрессирующей миопии, за проанализированный период. Работы демонстрируют важность использования современных оптических методов – очковых линз, мультифокальных и бифокальных мягких контактных линз, а также ортокератологии – в рутинной практике офтальмологов и оптометристов с целью стабилизации прогрессирования миопии у детей и подростков. Результаты анализа исследований показывают, с одной стороны, их высокую эффективность, а с другой – необходимость индивидуального подхода в выборе метода контроля миопии. Выделены факторы, влияющие на результат: диаметр оптической зоны, сила аддидации, формирующая наведенный периферический миопический дефокус, а также время использования в течение дня.</p></sec><sec><title>Заключение</title><p>Заключение. Ни один метод лечения прогрессирующей миопии не демонстрирует явного превосходства. Ортокератологические, мультифокальные и бифокальные мягкие контактные линзы, специальные очки и низкие дозы атропина показывают аналогичный эффект с некоторыми оговорками. При выборе оптических методов контроля миопии следует учитывать факторы, влияющие на их эффективность.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Myopia is the main cause of preventable blindness and is widespread around the world at an alarming rate, especially in Asian countries. The age of the onset of myopia is getting younger. The prevalence of myopia and high myopia is sharply increasing, which requires clinicians to use new and safe methods of its stabilization. The main methods of correction are optical. This group is based on the hypothesis of induced peripheral myopic defocus.</p></sec><sec><title>Aim</title><p>Aim: to study the domestic and international experience with the use of the optical methods in treatment of progressive myopia according to the literature and factors, as well as factors affecting their effectiveness.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. More than 200 publications on PubMed, eLibrary, and Crossref Metadata over the past 10 years were analyzed. Our analysis includes a review of 60 publications.</p></sec><sec><title>Results</title><p>Results. Over the past years, there has been a strong interest of researchers in the problem of progressive myopia. This is reflected by a more than four-fold increase in the number of publications devoted to the causes and methods of treatment in patients with progressive myopia. Publications demonstrate the importance of using the modern optical methods, such as spectacle lenses, multifocal and bifocal soft contact lenses and orthokeratology in the routine practice of ophthalmologists and optometrists in order to stabilize the progression of myopia in children and adolescents. On the one hand, the results of analysis show their high efficiency. On the other hand, we need an individual approach in choosing the method for myopia control in each specific case. The factors influencing the result are identified: the diameter of the optical zone, the force of addition that creates the peripheral myopic defocus and the time of use myopia correction during the day.</p></sec><sec><title>Conclusion</title><p>Conclusion. No method of treating progressive myopia demonstrates clear superiority. Orthokeratology, multifocal and bifocal soft contact lenses, special glasses and low doses atropine instillation demonstrates the similar effect with some clauses. When choosing optical methods for myopia control, the factors affecting their effectiveness should be taken into account.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>прогрессирующая миопия</kwd><kwd>близорукость</kwd><kwd>контроль миопии</kwd><kwd>ортокератология</kwd><kwd>бифокальные контактные линзы</kwd><kwd>мультифокальные контактные линзы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>progressive myopia</kwd><kwd>myopia control</kwd><kwd>orthokeratology</kwd><kwd>bifocal contact lenses</kwd><kwd>multifocal contact lenses</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Morgan I.G., Ohno-Matsui K., Saw S.M. Myopia. Lancet. 2012;379(9827):1739–1748. https://doi.org/10.1016/S0140-6736(12)60272-4</mixed-citation><mixed-citation xml:lang="en">Morgan I.G., Ohno-Matsui K., Saw S.M. Myopia. Lancet. 2012;379(9827):1739–1748. https://doi.org/10.1016/S0140-6736(12)60272-4</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P. et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006</mixed-citation><mixed-citation xml:lang="en">Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P. et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wu P.C., Chuang M.N., Choi J., Chen H., Wu G., Ohno-Matsui K. et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond.). 2019;33(1):3–13. https://doi.org/10.1038/s41433-018-0139-7</mixed-citation><mixed-citation xml:lang="en">Wu P.C., Chuang M.N., Choi J., Chen H., Wu G., Ohno-Matsui K. et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond.). 2019;33(1):3–13. https://doi.org/10.1038/s41433-018-0139-7</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chua S.Y., Sabanayagam C., Cheung Y.B., Chia A., Valenzuela R.K., Tan D. et al. Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children. Ophthalmic Physiol Opt. 2016;36(4):388–394. https://doi.org/10.1111/opo.12305</mixed-citation><mixed-citation xml:lang="en">Chua S.Y., Sabanayagam C., Cheung Y.B., Chia A., Valenzuela R.K., Tan D. et al. Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children. Ophthalmic Physiol Opt. 2016;36(4):388–394. https://doi.org/10.1111/opo.12305</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pärssinen O., Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmol. 2019;97(5):510–518. https://doi.org/10.1111/aos.13964</mixed-citation><mixed-citation xml:lang="en">Pärssinen O., Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmol. 2019;97(5):510–518. https://doi.org/10.1111/aos.13964</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hu Y., Ding X., Guo X., Chen Y., Zhang J., He M. Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort. JAMA Ophthalmol. 2020;138(11):1129–1134. https://doi.org/10.1001/jamaophthalmol.2020.3451</mixed-citation><mixed-citation xml:lang="en">Hu Y., Ding X., Guo X., Chen Y., Zhang J., He M. Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort. JAMA Ophthalmol. 2020;138(11):1129–1134. https://doi.org/10.1001/jamaophthalmol.2020.3451</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Проскурина О.В., Маркова Е.Ю., Бржеский В.В., Ефимова Е.Л., Ефимова М.Н., Хватова Н.В. и др. Распространенность миопии у школьников некоторых регионов России. Офтальмология. 2018;15(3):348–353. https://doi.org/10.18008/1816-5095-2018-3-348-353</mixed-citation><mixed-citation xml:lang="en">Proskurina O.V., Markova E.Y., Brzheskij V.V., Efimova E.L., Efimova M.N., Khvatova N.N. et al. The prevalence of myopia in schoolchildren in some regions of Russia. Ophthalmology in Russia. 2018;15(3):348–353. (In Russ.) https://doi.org/10.18008/1816-5095-2018-3-348-353</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jones D., Luensmann D. The prevalence and impact of high myopia. Eye Contact Lens. 2012;38(3):188–196. https://doi.org/10.1097/ICL.0b013e31824ccbc3</mixed-citation><mixed-citation xml:lang="en">Jones D., Luensmann D. The prevalence and impact of high myopia. Eye Contact Lens. 2012;38(3):188–196. https://doi.org/10.1097/ICL.0b013e31824ccbc3</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fricke T.R., Jong M., Naidoo K.S., Sankaridurg P., Naduvilath T.J., Ho S.M. et al. Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Br J Ophthalmol. 2018;102(7):855–862. https://doi.org/10.1136/bjophthalmol-2017-311266</mixed-citation><mixed-citation xml:lang="en">Fricke T.R., Jong M., Naidoo K.S., Sankaridurg P., Naduvilath T.J., Ho S.M. et al. Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Br J Ophthalmol. 2018;102(7):855–862. https://doi.org/10.1136/bjophthalmol-2017-311266</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wong T.Y., Ferreira A., Hughes R., Carter G., Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol. 2014;157(1):9–25.e12. https://doi.org/10.1016/j.ajo.2013.08.010</mixed-citation><mixed-citation xml:lang="en">Wong T.Y., Ferreira A., Hughes R., Carter G., Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol. 2014;157(1):9–25.e12. https://doi.org/10.1016/j.ajo.2013.08.010</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Haarman A.E.G., Enthoven C.A., Tideman J.W.L., Tedja M.S., Verhoeven V.J.M., Klaver C.C.W. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(4):49. https://doi.org/10.1167/iovs.61.4.49</mixed-citation><mixed-citation xml:lang="en">Haarman A.E.G., Enthoven C.A., Tideman J.W.L., Tedja M.S., Verhoeven V.J.M., Klaver C.C.W. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(4):49. https://doi.org/10.1167/iovs.61.4.49</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Проскурина О.В., Иомдина ЕН. Контроль миопии в реальной клинической практике: результаты экспертного исследования. Офтальмология. 2021;18(4):962–971. https://doi.org/10.18008/1816-5095-2021-4-962-971</mixed-citation><mixed-citation xml:lang="en">Tarutta E.P., Proskurina O.V., Iomdina E.N. The myopia control in real clinical practice: the results of an expert study. Ophthalmology in Russia. 2021;18(4):962–971. (In Russ.) https://doi.org/10.18008/1816-5095-2021-4-962-971</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yazdani N., Sadeghi R., Ehsaei A., Taghipour A., Hasanzadeh S., Zarifmahmoudi L., Heravian Shandiz J. Under-correction or full correction of myopia? A meta-analysis. J Optom. 2021;14(1):11–19. https://doi.org/10.1016/j.optom.2020.04.003</mixed-citation><mixed-citation xml:lang="en">Yazdani N., Sadeghi R., Ehsaei A., Taghipour A., Hasanzadeh S., Zarifmahmoudi L. et al. Under-correction or full correction of myopia? A meta-analysis. J Optom. 2021;14(1):11–19. https://doi.org/10.1016/j.optom.2020.04.003</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Проскурина О.В., Тарасова Н.А., Милаш С.В., Маркосян Г.А. Отдаленные результаты очковой коррекции с перифокальным дефокусом у детей с прогрессирующей миопией. Вестник офтальмологии. 2019;135(5):46–53. https://doi.org/10.17116/oftalma201913505146</mixed-citation><mixed-citation xml:lang="en">Tarutta E.P., Proskurina O.V., Tarasova N.A., Milash S.V., Markosian G.A. Long-term results of perifocal defocus spectacle lens correction in children with progressive myopia. Vestnik Oftalmologii. 2019;135(5):46–53. (In Russ.) https://doi.org/10.17116/oftalma201913505146</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lam C.S.Y., Tang W.C., Tse D.Y., Lee R.P.K., Chun R.K.M., Hasegawa K., Qi H. et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363–368. https://doi.org/10.1136/bjophthalmol-2018-313739.</mixed-citation><mixed-citation xml:lang="en">Lam C.S.Y., Tang W.C., Tse D.Y., Lee R.P.K., Chun R.K.M., Hasegawa K., Qi H. et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363–368. https://doi.org/10.1136/bjophthalmol-2018-313739.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kaymak H., Graff B., Neller K., Langenbucher A., Seitz B., Schwahn H. Myopietherapie und Prophylaxe mit “Defocus Incorporated Multiple Segments” Brillengläsern. Ophthalmologe. 2021;118(12):1280–1286. https://doi.org/10.1007/s00347-021-01452-y</mixed-citation><mixed-citation xml:lang="en">Kaymak H., Graff B., Neller K., Langenbucher A., Seitz B., Schwahn H. Myopietherapie und Prophylaxe mit “Defocus Incorporated Multiple Segments” Brillengläsern. Ophthalmologe. 2021;118(12):1280–1286. https://doi.org/10.1007/s00347-021-01452-y</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lam C.S., Tang W.C., Lee P.H., Zhang H.Y., Qi H., Hasegawa K. et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022;106(8):1110–1114. https://doi.org/10.1136/bjophthalmol-2020-317664</mixed-citation><mixed-citation xml:lang="en">Lam C.S., Tang W.C., Lee P.H., Zhang H.Y., Qi H., Hasegawa K. et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022;106(8):1110–1114. https://doi.org/10.1136/bjophthalmol-2020-317664</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y., Fu Y., Wang K., Liu Z., Shi X., Zhao M. Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial. Trials. 2020;21(1):279. https://doi.org/10.1186/s13063-020-4095-8</mixed-citation><mixed-citation xml:lang="en">Li Y., Fu Y., Wang K., Liu Z., Shi X., Zhao M. Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial. Trials. 2020;21(1):279. https://doi.org/10.1186/s13063-020-4095-8</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bao J., Huang Y., Li X., Yang A., Zhou F., Wu J. et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022;140(5):472–478. https://doi.org/10.1001/jamaophthalmol.2022.0401</mixed-citation><mixed-citation xml:lang="en">Bao J., Huang Y., Li X., Yang A., Zhou F., Wu J. et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022;140(5):472–478. https://doi.org/10.1001/jamaophthalmol.2022.0401</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Проскурина О.В., Тарасова Н.А., Маркосян Г.А., Арутюнян С.Г., Милаш С.В., Тарутта Е.П. Адаптация и качество зрения в очках с линзами для контроля миопии Stellest с встроенными высокоасферичными микролинзами. Российская педиатрическая офтальмология. 2022;17(2):5–12. https://doi.org/10.17816/rpoj97296</mixed-citation><mixed-citation xml:lang="en">Proskurima O.V., Tarasova N.A., Markosyan G.A., Arutunayan S.G., Milash S.V., Tarutta Е.Р. Adaptation and quality of vision in glasses with lenses for the control of Stellest myopia with built-in high-spherical microlenses. Russian Pediatric Ophthalmology. 2022;17(2):5–12. https://doi.org/10.17816/rpoj97296</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Huang J., Wen D., Wang Q., McAlinden C., Flitcroft I., Chen H. et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology. 2016;123(4):697–708. https://doi.org/10.1016/j.ophtha.2015.11.010.</mixed-citation><mixed-citation xml:lang="en">Huang J., Wen D., Wang Q., McAlinden C., Flitcroft I., Chen H. et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology. 2016;123(4):697–708. https://doi.org/10.1016/j.ophtha.2015.11.010.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sankaridurg P., Bakaraju R.C., Naduvilath T., Chen X., Weng R., Tilia D. et al. Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial. Ophthalmic Physiol Opt. 2019;39:294–307. https://doi.org/10.1111/opo.12621</mixed-citation><mixed-citation xml:lang="en">Sankaridurg P., Bakaraju R.C., Naduvilath T., Chen X., Weng R., Tilia D. et al. Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial. Ophthalmic Physiol Opt. 2019;39:294–307. https://doi.org/10.1111/opo.12621</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Чемберлен П., Пейшото-де-Матос С.К., Логан Н.С., Нго Ч., Джонс Д., Янг Г. 3-летнее рандомизированное клиническое исследование линз MiSight для замедления прогрессирования миопии. The EYE ГЛАЗ. 2020;22(4):11–28. https://doi.org/10.33791/2222-4408-2020-4-11-28</mixed-citation><mixed-citation xml:lang="en">Chamberlain P., Peixoto-de-Matos Sofia C., Logan N.S., Ngo Ch., Jones D., Young G. A 3-year randomized clinical trial of misight lenses for slowing myopia progression. The EYE GLAZ. 2020:22(4):11–28. (In Russ.) https://doi.org/10.33791/2222-4408-2020-4-11-28</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Del Valle A.M., Blázquez V., Gros-Otero J., Infante M., Culebras A., Verdejo A. et al. Efficacy and safety of a soft contact lens to control myopia progression. Clin Exp Optom. 2021;104(1):14–21. https://doi.org/10.1111/cxo.13077</mixed-citation><mixed-citation xml:lang="en">Garcia-Del Valle A.M., Blázquez V., Gros-Otero J., Infante M., Culebras A., Verdejo A. et al. Efficacy and safety of a soft contact lens to control myopia progression. Clin Exp Optom. 2021;104(1):14–21. https://doi.org/10.1111/cxo.13077</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Yu Z., Zhong A., Zhao X., Li D., Duan J. Efficacy and safety of different add power soft contact lenses on myopia progression in children: a systematic review and meta-analysis. Ophthalmic Res. 2022;65(4):398–416. https://doi.org/10.1159/000523675</mixed-citation><mixed-citation xml:lang="en">Yu Z., Zhong A., Zhao X., Li D., Duan J. Efficacy and safety of different add power soft contact lenses on myopia progression in children: a systematic review and meta-analysis. Ophthalmic Res. 2022;65(4):398–416. https://doi.org/10.1159/000523675</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Fujikado T., Ninomiya S., Kobayashi T., Suzaki A., Nakada M., Nishida K. Effect of low-addition soft contact lenses with decentered optical design on myopia progression in children: a pilot study. Clin Ophthalmol. 2014;8:1947–1956. https://doi.org/10.2147/OPTH.S66884.</mixed-citation><mixed-citation xml:lang="en">Fujikado T., Ninomiya S., Kobayashi T., Suzaki A., Nakada M., Nishida K. Effect of low-addition soft contact lenses with decentered optical design on myopia progression in children: a pilot study. Clin Ophthalmol. 2014;8:1947–1956. https://doi.org/10.2147/OPTH.S66884.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Allinjawi K., Kaur S., Akhir S.M., Mutalib H.A. Inverting peripheral hyperopic defocus into myopic defocus among myopic schoolchildren using addition power of multifocal contact lens. Saudi J Ophthalmol. 2020;34(2):94–100. https://doi.org/10.4103/1319-4534.305035.</mixed-citation><mixed-citation xml:lang="en">Allinjawi K., Kaur S., Akhir S.M., Mutalib H.A. Inverting peripheral hyperopic defocus into myopic defocus among myopic schoolchildren using addition power of multifocal contact lens. Saudi J Ophthalmol. 2020;34(2):94–100. https://doi.org/10.4103/1319-4534.305035.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Аветисов С.Э., Мягков А.В., Егорова А.В., Поскребышева Ж.Н., Жабина О.А. Результаты двухлетнего клинического исследования контроля миопии с помощью бифокальных дефокусных мягких контактных линз. Вестник офтальмологии. 2021;137(3):5–12. https://doi.org/10.17116/oftalma20211370315.</mixed-citation><mixed-citation xml:lang="en">Avetisov S.E., Myagkov A.V., Egorova A.V., Poskrebysheva Z.N., Zhabina O.A. Results of a two-year clinical study of myopia control with bifocal defocus-inducing soft contact lenses. Vestnik Oftalmologii. 2021;137(3):5–12. (In Russ.) https://doi.org/10.17116/oftalma20211370315.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Проскурина О.В., Маркосян Г.А., Милаш С.В., Тарасова Н.А., Ходжабекян Н.В. Стратегически ориентированная концепция оптической профилактики возникновения и прогрессирования миопии. Российский офтальмологический журнал. 2020;13(4):7–16. https://doi.org/10.21516/2072-0076-2020-13-4-7-16</mixed-citation><mixed-citation xml:lang="en">Tarutta Е.P., Proskurina O.V., Markossian G.A., Milash S.V., Tarasova N.A., Khodzhabekyan N.V. A strategically oriented conception of optical prevention of myopia onset and progression. Russian Ophthalmological Journal. 2020;13(4):7–16. (In Russ.) https://doi.org/10.21516/2072-0076-2020-13-4-7-16</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Prousali E., Haidich A.B., Fontalis A., Ziakas N., Brazitikos P., Mataftsi A. Efficacy and safety of interventions to control myopia progression in children: an overview of systematic reviews and meta-analyses. BMC Ophthalmol. 2019;19(1):106. https://doi.org/10.1186/s12886-019-1112-3</mixed-citation><mixed-citation xml:lang="en">Prousali E., Haidich A.B., Fontalis A., Ziakas N., Brazitikos P., Mataftsi A. Efficacy and safety of interventions to control myopia progression in children: an overview of systematic reviews and meta-analyses. BMC Ophthalmol. 2019;19(1):106. https://doi.org/10.1186/s12886-019-1112-3</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Russo A., Boldini A., Romano D., Mazza G., Bignotti S., Morescalchi F. et al. Myopia: mechanisms and strategies to slow down its progression. J Ophthalmol. 2022;2022:1004977. https://doi.org/10.1155/2022/1004977.</mixed-citation><mixed-citation xml:lang="en">Russo A., Boldini A., Romano D., Mazza G., Bignotti S., Morescalchi F. et al. Myopia: mechanisms and strategies to slow down its progression. J Ophthalmol. 2022;2022:1004977. https://doi.org/10.1155/2022/1004977.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Жабина О.А., Андриенко Г.В. Ортокератологические линзы для контроля миопии. Факторы, влияющие на эффективность метода (обзор литературы). The EYE ГЛАЗ. 2021;23(3):47–52. https://doi.org/10.33791/2222-4408-2021-3-47-52</mixed-citation><mixed-citation xml:lang="en">Zhabina O.A., Andrienko G.V. Orthokeratology lenses for myopia control. factors affecting efficacy (literature review). The EYE GLAZ. 2021;23(3):47–52. (In Russ.) https://doi.org/10.33791/2222-4408-2021-3-47-52</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Chen R., Mao X., Jiang J., Shen M., Lian Y., Zhang B. et al. The relationship between corneal biomechanics and anterior segment parameters in the early stage of orthokeratology: A pilot study. Medicine (Baltimore). 2017;96(19):e6907. https://doi.org/10.1097/MD.0000000000006907.</mixed-citation><mixed-citation xml:lang="en">Chen R., Mao X., Jiang J., Shen M., Lian Y., Zhang B. et al. The relationship between corneal biomechanics and anterior segment parameters in the early stage of orthokeratology: A pilot study. Medicine (Baltimore). 2017;96(19):e6907. https://doi.org/10.1097/MD.0000000000006907.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Sankaridurg P., Conrad F., Tran H., Zhu J. Controlling progression of myopia: optical and pharmaceutical strategies. Asia Pac J Ophthalmol (Phila). 2018;7(6):405–414. https://doi.org/10.22608/APO.2018333.</mixed-citation><mixed-citation xml:lang="en">Sankaridurg P., Conrad F., Tran H., Zhu J. Controlling progression of myopia: optical and pharmaceutical strategies. Asia Pac J Ophthalmol (Phila). 2018;7(6):405–414. https://doi.org/10.22608/APO.2018333.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung S.W., Boost M.V., Cho P. Pre-treatment observation of axial elongation for evidence-based selection of children in Hong Kong for myopia control. Cont Lens Anterior Eye. 2019;42(4):392–398. https://doi.org/10.1016/j.clae.2018.10.006.</mixed-citation><mixed-citation xml:lang="en">Cheung S.W., Boost M.V., Cho P. Pre-treatment observation of axial elongation for evidence-based selection of children in Hong Kong for myopia control. Cont Lens Anterior Eye. 2019;42(4):392–398. https://doi.org/10.1016/j.clae.2018.10.006.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Santodomingo-Rubido J., Villa-Collar C., Gilmartin B., Gutiérrez-Ortega R. Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53(8):5060–5065. https://doi.org/10.1167/iovs.11-8005.</mixed-citation><mixed-citation xml:lang="en">Santodomingo-Rubido J., Villa-Collar C., Gilmartin B., Gutiérrez-Ortega R. Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53(8):5060–5065. https://doi.org/10.1167/iovs.11-8005.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Cho P., Cheung S.W. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077–7085. https://doi.org/10.1167/iovs.12-10565.</mixed-citation><mixed-citation xml:lang="en">Cho P., Cheung S.W. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077–7085. https://doi.org/10.1167/iovs.12-10565.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Huang J., Wen D., Wang Q., McAlinden C., Flitcroft I., Chen H. et al. Efficacy comparison of 16 interventions for myopia control in children: A network meta-analysis. Ophthalmology. 2016;123(4):697–708. https://doi.org/10.1016/j.ophtha.2015.11.010.</mixed-citation><mixed-citation xml:lang="en">Huang J., Wen D., Wang Q., McAlinden C., Flitcroft I., Chen H. et al. Efficacy comparison of 16 interventions for myopia control in children: A network meta-analysis. Ophthalmology. 2016;123(4):697–708. https://doi.org/10.1016/j.ophtha.2015.11.010.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Вержанская Т.Ю. Стабилизирующий эффект ортокератологической коррекции миопии (результаты десятилетнего динамического наблюдения). Вестник офтальмологии. 2017;133(1):49–54. https://doi.org/10.17116/oftalma2017133149-54</mixed-citation><mixed-citation xml:lang="en">Tarutta E.P., Verzhanskaya T.Y. Stabiliziruyushchii effekt ortokeratologicheskoi korrektsii miopii (rezul’taty desyatiletnego dinamicheskogo nablyudeniya) [Stabilizing effect of orthokeratology lenses (ten-year follow-up results)]. Vestn Oftalmol. 2017;133(1):49–54. (In Russ.) https://doi.org/10.17116/oftalma2017133149-54</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Vincent S.J., Cho P., Chan K.Y., Fadel D., Ghorbani-Mojarrad N., González-Méijome J.M. et al. CLEAR – Orthokeratology. Cont Lens Anterior Eye. 2021;44(2):240–269. https://doi.org/10.1016/j.clae.2021.02.003.</mixed-citation><mixed-citation xml:lang="en">Vincent S.J., Cho P., Chan K.Y., Fadel D., Ghorbani-Mojarrad N., González-Méijome J.M. et al. CLEAR – Orthokeratology. Cont Lens Anterior Eye. 2021;44(2):240–269. https://doi.org/10.1016/j.clae.2021.02.003.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Матросова Ю.В., Товмач Л.Н. Прогрессирование миопии на фоне ортокератологической коррекции по данным оптической биометрии. Саратовский научно-медицинский журнал. 2020;16 (1):245–248. https://ssmj.ru/2020/1/245?ysclid=lezqcjw173869031676</mixed-citation><mixed-citation xml:lang="en">Matrosova Yu.V., Tovmach L.N. Myopic progression in association with orthokeratological correction according to the optical biometry data. Saratov Journal of Medical Scientific Research. 2020;16(1):245–248. (In Russ.) https://ssmj.ru/2020/1/245?ysclid=lezqcjw173869031676</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Parkhomets R.A. Efficacy of orthokeratology lenses depending on topograpy pupil diameter and lens optical zone size. J Ophthalmol (Ukraine). 2021;4:67–71. http://doi.org/10.31288/oftalmolzh202146771</mixed-citation><mixed-citation xml:lang="en">Parkhomets R.A. Efficacy of orthokeratology lenses depending on topograpy pupil diameter and lens optical zone size. J Ophthalmol (Ukraine). 2021;4:67–71. http://doi.org/10.31288/oftalmolzh202146771</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Michaud L., Simard P. Myopia control with ORTHO-K. Contact Lens Spectrum. 2017;32:20–26.</mixed-citation><mixed-citation xml:lang="en">Michaud L., Simard P. Myopia control with ORTHO-K. Contact Lens Spectrum. 2017;32:20–26.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Жабина О.А., Листратов С.В., Мягков А.В., Поскребышева Ж.Н. Патент Ортокератологическая линза для замедления развития близорукости. Патент RU 2780271 C1, 21.09.2022.</mixed-citation><mixed-citation xml:lang="en">Zhabina O.A., Listratov S.V., Myagkov A.V., Poskrebysheva Zh.N. Orthokeratological lens to slow down the development of myopia. Patent RU 2780271 C1, 21.09.2022. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Na M., Yoo A. The effect of orthokeratology on axial length elongation in children with myopia: Contralateral comparison study. Jpn J Ophthalmol. 2018;62(3):327–334. https://doi.org/10.1007/s10384-018-0573-x</mixed-citation><mixed-citation xml:lang="en">Na M., Yoo A. The effect of orthokeratology on axial length elongation in children with myopia: Contralateral comparison study. Jpn J Ophthalmol. 2018;62(3):327–334. https://doi.org/10.1007/s10384-018-0573-x</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao C., Cai C., Dai H., Zhang J. Effect of the combined application of orthokeratology and single-vision spectacles on slowing the progression of high myopia: A systematic review and meta-analysis. Medicine (Baltimore). 2022;101(33):e30178. https://doi.org/10.1097/MD.0000000000030178.</mixed-citation><mixed-citation xml:lang="en">Zhao C., Cai C., Dai H., Zhang J. Effect of the combined application of orthokeratology and single-vision spectacles on slowing the progression of high myopia: A systematic review and meta-analysis. Medicine (Baltimore). 2022;101(33):e30178. https://doi.org/10.1097/MD.0000000000030178.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Li S.M., Wu S.S., Kang M.T., Liu Y., Jia S.M., Li S.Y. et al. Atropine slows myopia progression more in Asian than white children by meta-analysis. Optom Vis Sci. 2014;91(3):342-50. https://doi.org/10.1097/OPX.0000000000000178</mixed-citation><mixed-citation xml:lang="en">Li S.M., Wu S.S., Kang M.T., Liu Y., Jia S.M., Li S.Y. et al. Atropine slows myopia progression more in Asian than white children by meta-analysis. Optom Vis Sci. 2014;91(3):342-50. https://doi.org/10.1097/OPX.0000000000000178</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai H.R., Wang J.H., Huang H.K., Chen T.L., Chen P.W., Chiu C.J. Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis. J Formos Med Assoc. 2022;121(12):2490–2500. https://doi.org/10.1016/j.jfma.2022.05.005</mixed-citation><mixed-citation xml:lang="en">Tsai H.R., Wang J.H., Huang H.K., Chen T.L., Chen P.W., Chiu C.J. Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis. J Formos Med Assoc. 2022;121(12):2490–2500. https://doi.org/10.1016/j.jfma.2022.05.005</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Вержанская Т.Ю. Эффективность ортокератологической коррекции в сочетании с инстилляциями сверхмалых концентраций атропина при прогрессирующей миопии. The EYE ГЛАЗ. 2019;21(2 (126)):22–30. https://doi.org/10.33791/2222-4408-2019-2-22-30</mixed-citation><mixed-citation xml:lang="en">Tarutta E.P., Verzhanskaya T.Yu. Efficacy of myopia control by combination of orthokeratology and instillation  of  low-concentration  atropine.  The  EYE GLAZ. 2019;21(2(126)):22–30. (In Russ.) https://doi.org/10.33791/2222-4408-2019-2-22-30</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Tideman J.W., Snabel M.C., Tedja M.S., van Rijn G.A., Wong K.T., Kuijpers R.W. et al. Association of axial length with risk of uncorrectable visual impairment for europeans with myopia. JAMA Ophthalmol. 201;134(12):1355–1363. https://doi.org/10.1001/jamaophthalmol.2016.4009.</mixed-citation><mixed-citation xml:lang="en">Tideman J.W., Snabel M.C., Tedja M.S., van Rijn G.A., Wong K.T., Kuijpers R.W. et al. Association of axial length with risk of uncorrectable visual impairment for europeans with myopia. JAMA Ophthalmol. 201;134(12):1355–1363. https://doi.org/10.1001/jamaophthalmol.2016.4009.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">McCrann S., Flitcroft I., Loughman J. Is optometry ready for myopia control? Education and other barriers to the treatment of myopia. HRB Open Research. 2020;2:30. https://doi.org/10.12688/hrbopenres.12954.2</mixed-citation><mixed-citation xml:lang="en">McCrann S., Flitcroft I., Loughman J. Is optometry ready for myopia control? Education and other barriers to the treatment of myopia. HRB Open Research. 2020;2:30. https://doi.org/10.12688/hrbopenres.12954.2</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Brennan N.A., Toubouti Y.M., Cheng X., Bullimore M.A. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923. https://doi.org/10.1016/j.preteyeres.2020.100923</mixed-citation><mixed-citation xml:lang="en">Brennan N.A., Toubouti Y.M., Cheng X., Bullimore M.A. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923. https://doi.org/10.1016/j.preteyeres.2020.100923</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Lam C.S., Tang W.C., Tse D.Y., Tang Y.Y., To C.H. Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial. Br J Ophthalmol. 2014;98(1):40–45. https://doi.org/10.1136/bjophthalmol-2013-303914.</mixed-citation><mixed-citation xml:lang="en">Lam C.S., Tang W.C., Tse D.Y., Tang Y.Y., To C.H. Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial. Br J Ophthalmol. 2014;98(1):40–45. https://doi.org/10.1136/bjophthalmol-2013-303914.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Walline J.J., Gaume Giannoni A., Sinnott L.T., Chandler M.A., Huang J., Mutti D.O. et al; BLINK Study Group. A randomized trial of soft multifocal contact lenses for myopia control: baseline data and methods. Optom Vis Sci. 201;94(9):856–866. https://doi.org/10.1097/OPX.0000000000001106.</mixed-citation><mixed-citation xml:lang="en">Walline J.J., Gaume Giannoni A., Sinnott L.T., Chandler M.A., Huang J., Mutti D.O. et al; BLINK Study Group. A randomized trial of soft multifocal contact lenses for myopia control: baseline data and methods. Optom Vis Sci. 201;94(9):856–866. https://doi.org/10.1097/OPX.0000000000001106.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Plainis S., Atchison D.A., Charman W.N. Power profiles of multifocal contact lenses and their interpretation. Optom Vis Sci. 2013;90(10):1066–1077. https://doi.org/10.1097/OPX.0000000000000030.</mixed-citation><mixed-citation xml:lang="en">Plainis S., Atchison D.A., Charman W.N. Power profiles of multifocal contact lenses and their interpretation. Optom Vis Sci. 2013;90(10):1066–1077. https://doi.org/10.1097/OPX.0000000000000030.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Cardona G., López S. Pupil diameter, working distance and illumination during habitual tasks. Implications for simultaneous vision contact lenses for presbyopia. J Optom. 2016;9(2):78–84. https://doi.org/10.1016/j.optom.2015.06.005..</mixed-citation><mixed-citation xml:lang="en">Cardona G., López S. Pupil diameter, working distance and illumination during habitual tasks. Implications for simultaneous vision contact lenses for presbyopia. J Optom. 2016;9(2):78–84. https://doi.org/10.1016/j.optom.2015.06.005..</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Madrid-Costa D., Ruiz-Alcocer J., García-Lázaro S., Ferrer-Blasco T., Montés-Micó R. Optical power distribution of refractive and aspheric multifocal contact lenses: Effect of pupil size. Cont Lens Anterior Eye. 2015;38(5):317–321. https://doi.org/10.1016/j.clae.2015.03.008.</mixed-citation><mixed-citation xml:lang="en">Madrid-Costa D., Ruiz-Alcocer J., García-Lázaro S., Ferrer-Blasco T., Montés-Micó R. Optical power distribution of refractive and aspheric multifocal contact lenses: Effect of pupil size. Cont Lens Anterior Eye. 2015;38(5):317–321. https://doi.org/10.1016/j.clae.2015.03.008.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Wagner S., Conrad F., Bakaraju R.C., Fedtke C., Ehrmann K., Holden B.A. Power profiles of single vision and multifocal soft contact lenses. Cont Lens Anterior Eye. 2015;38(1):2–14. https://doi.org/10.1016/j.clae.2014.07.008.</mixed-citation><mixed-citation xml:lang="en">Wagner S., Conrad F., Bakaraju R.C., Fedtke C., Ehrmann K., Holden B.A. Power profiles of single vision and multifocal soft contact lenses. Cont Lens Anterior Eye. 2015;38(1):2–14. https://doi.org/10.1016/j.clae.2014.07.008.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Слышалова Н.Н., Хватова Н.В. Наш опыт применения бифокальных мягких контактных линз у детей с прогрессирующей близорукостью. The EYE ГЛАЗ. 2021;23(2):19–26. https://doi.org/10.33791/2222-4408-2021-2-19-26</mixed-citation><mixed-citation xml:lang="en">Slyshalova N.N., Khvatova N.V. Our Experience of using soft bifocal contact lenses in children with progressive myopia. The EYE GLAZ. 2021;23(2):19–26. (In Russ.) https://doi.org/10.33791/2222-4408-2021-2-19-26</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Bullimore M.A., Brennan N.A. Myopia control: why each diopter matters. Optom Vis Sci. 2019;96(6):463–465. https://doi.org/10.1097/OPX.0000000000001367.</mixed-citation><mixed-citation xml:lang="en">Bullimore M.A., Brennan N.A. Myopia control: why each diopter matters. Optom Vis Sci. 2019;96(6):463–465. https://doi.org/10.1097/OPX.0000000000001367.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
